GMAB
Genmab A/S Healthcare - Biotechnology Investor Relations →
Genmab A/S (GMAB) closed at $30.90 as of 2026-02-02, trading 0.5% above its 200-week moving average of $30.73. The stock is currently moving closer to the line, down from 6.1% last week. The 14-week RSI sits at 56, indicating neutral momentum.
Over the past 822 weeks of data, GMAB has crossed below its 200-week moving average 7 times. On average, these episodes lasted 37 weeks. Historically, investors who bought GMAB at the start of these episodes saw an average one-year return of +30.4%.
With a market cap of $19.0 billion, GMAB is a large-cap stock. The company generates a free cash flow yield of 5.0%, which is healthy. Return on equity stands at 29.4%, indicating strong profitability. The stock trades at 0.3x book value.
Management has been repurchasing shares, with a 3.3% reduction over three years. GMAB passes our Buffett quality screen: high return on equity, low debt, and positive free cash flow.
Over the past 15.8 years, a hypothetical investment of $100 in GMAB would have grown to $3768, compared to $838 for the S&P 500. That represents an annualized return of 25.8% vs 14.4% for the index — confirming GMAB as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been growing at a 51.3% compound annual rate, with 4 consecutive years of positive cash generation.
Growth of $100: GMAB vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After GMAB Crosses Below the Line?
Across 7 historical episodes, buying GMAB when it crossed below its 200-week moving average produced an average return of +37.8% after 12 months (median +57.0%), compared to +21.5% for the S&P 500 over the same periods. 83% of those episodes were profitable after one year. After 24 months, the average return was +63.5% vs +43.2% for the index.
Each line shows $100 invested at the moment GMAB crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
GMAB has crossed below its 200-week MA 7 times with an average 1-year return of +30.4% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| May 2010 | Dec 2012 | 134 | 66.2% | +42.1% | +3152.6% |
| Oct 2018 | Dec 2018 | 10 | 19.6% | +27.3% | +102.2% |
| Jan 2019 | Feb 2019 | 5 | 9.6% | +45.5% | +97.6% |
| May 2019 | May 2019 | 1 | 0.6% | +65.2% | +85.5% |
| Jun 2022 | Jun 2022 | 2 | 2.1% | +33.3% | +7.0% |
| Sep 2023 | Sep 2025 | 105 | 45.6% | -31.0% | -12.4% |
| Oct 2025 | Nov 2025 | 5 | 7.4% | N/A | +3.4% |
| Average | 37 | — | +30.4% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02